Astec LifeSciences Limited — Important, 27-03-2025: Disclosure Under Regulation 51

The company has announced a board meeting on [date] to discuss its financial results for the quarter and half-year. This update indicates ongoing oversight and transparency regarding financial performance. Such discussions are vital for assessing the company's operational health and management effectiveness. Investors may view this as a positive outlook, reflecting the company’s commitment to maintaining clear communication and potentially enhancing shareholder value through informed decision-making. Keep an eye on how the results might influence market sentiment and investor confidence moving forward.